Skip to main content
. Author manuscript; available in PMC: 2017 Feb 15.
Published in final edited form as: J Immunol. 2016 Jan 13;196(4):1568–1578. doi: 10.4049/jimmunol.1501739

FIGURE 4.

FIGURE 4

Comparison of CD4+ or CD8+ TSCM populations within AA, uveitis, SLE, or SCD cohort. (A) CD4+ or CD8+ TSCM frequency was compared among AA (n = 55), uveitis (n = 34), SLE (n = 43), SCD (n = 5), and healthy control (n = 41) cohorts. * p < 0.05. (B) results of correlation Spearman rank tests in which CD4+ TSCM frequency was compared with CD8+ TSCM frequency within the same group (AA, uveitis, SLE, or healthy control groups). * p < 0.05; r, a correlation coefficient value.